版本:
中国

BRIEF-Astrazeneca divests rights to Rhinocort Aqua outside US

Oct 7 Astrazeneca Plc

* Enters agreement with Cilag GMBH International to divest rights to Rhinocort Aqua outside US

* $330 million payment received from Cilag gmbh international upon completion of transaction will be recognised as other operating income

* Transaction does not include transfer of any Astrazeneca employees or facilities and does not impact company's financial guidance

* AZ divests rights to Rhinocort Aqua outside US

* Agreement is subject to customary closing conditions and is expected to complete in Q4 of 2016 Source text for Eikon: Further company coverage: (London newsroom)

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐